Area of research
Pulmonary and Respiratory Medicine · Internal Medicine
Research interest
Research interests include Medicine, Idiopathic pulmonary fibrosis, Rivaroxaban, Pulmonary embolism, Quality of life (healthcare), and Intensive care medicine.
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Survival and quality of life after early discharge in low-risk pulmonary embolism
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban